BioCentury
ARTICLE | Company News

EMEA recommends SGP's Pegintron and Rebetol combination

December 20, 2000 8:00 AM UTC

The EMEA's Committee for Proprietary Medicinal Products (CPMP) recommended approval of Pegintron peginterferon alfa-2b, which is a longer-acting form of Schering-Plough's Intron A that uses polyethyle...